Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Purple Biotech Ltd (NASDAQ: PPBT)
PPBT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
PPBT Stock Analysis
PPBT
PE Ratio:
PPBT
PEG Ratio:
Not Available
PPBT
Forward EPS Growth (12 month):
0.00%
PPBT
PS Ratio:
PPBT
PSG Ratio:
Not Available
PPBT
Forward Revenue Growth (12 month):
0.00%
PPBT Articles
No data was found